A clinical trial to study the effect of N-acetyl cysteine (NAC)in patients with pulmonary tuberculosis
Phase 2
- Registration Number
- CTRI/2007/091/000012
- Lead Sponsor
- Christian Medical College - Vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult males or females who completed 18 years,detected to have sputum positive pulmonary tuberculosis, willing to take Anti tuberculous treatment under RNTCP - DOTS strategy
Exclusion Criteria
1) Co-existing chronic lung disease, 2) Pregnancy, 3) Patients not willing to enroll in DOTS, 4) Anemia other than nutritional anemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sputum smear conversion rateTimepoint: 1 month after the start of treatment;Sputum smear conversion rateTimepoint: 15 days
- Secondary Outcome Measures
Name Time Method Cure rate and relapse rateTimepoint: 2nd, 4th and 6th month after the start of treatment